News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
Are you interested in licensing or co-developing SARS-CoV-2 targeting antibodies? Investigators at the National Cancer Institute (NCI) have isolated a panel of anti-receptor binding domain (RBD) single domain antibodies (also called ‘nanobodies’) from camel single domain (VHH) phage display
IRP Senior Investigator and Inventor Dr. Peter Choyke has been elected to the National Academy of Medicine (NAM). Dr. Choyke is the Director of the National Cancer Institute’s Molecular Imaging Branch. He was elected for his work on improving diagnosis and treatment through imaging technologies for
The National Center for Advancing Translational Sciences (NCATS) Office of Strategic Alliances is hosting a f ederal technology transfer workshop focused on measuring impact, innovation, and efficiencies. This event is intended for technology transfer professionals, policy makers, and innovators to